Rhythm Pharmaceuticals, Inc. RYTM Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s operating cash flow?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported operating cash flow of -$44.19M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s operating cash flow changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s operating cash flow decreased by 9.5% year-over-year, from -$40.35M to -$44.19M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s operating cash flow has grown at a -5.7% compound annual growth rate (CAGR), from -$146M to -$115.68M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.